GLP-1 and GIP: How They Work

GLP-1 and GIP are naturally occurring hormones that help regulate appetite, blood sugar levels, digestion and energy metabolism. Medications such as tirzepatide mimic the activity of these hormones, working in several key areas of the body:

  • Brain: Reduces hunger and food cravings while increasing feelings of fullness.

  • Pancreas: Improves insulin response and blood sugar regulation.

  • Digestive Tract: Slows stomach emptying, helping individuals feel full longer.

  • Muscle and Fat Tissue: Improves insulin sensitivity and supports the utilization of stored fat for energy during weight loss.

Together, these effects support sustainable weight management, improved blood sugar control and better overall metabolic health when combined with proper nutrition and regular physical activity.

How GLP-1 Regulates Hunger and Appetite

Hunger and appetite are regulated by a region of the brain called the hypothalamus, which receives hormonal signals from the digestive system and fat tissue.

  • GLP-1: Released by the intestine after eating, it reduces appetite and promotes a feeling of fullness.

  • Leptin: Produced by fat tissue, it signals the brain that adequate energy stores are available, helping reduce hunger.

  • Ghrelin: Produced primarily by the stomach, it stimulates hunger and encourages food intake.

GLP-1 medications work with the body's natural appetite-regulating pathways to reduce hunger, decrease food cravings and prolong feelings of fullness. Together, these effects help patients reduce caloric intake and support long-term weight management.

GLP-1 and Digestive Function

GLP-1 is a naturally occurring hormone that helps regulate appetite, digestion, and blood sugar. GLP-1 medications activate receptors within the digestive system, slowing stomach emptying and reducing intestinal motility. As a result, food remains in the stomach longer, promoting a prolonged feeling of fullness (satiety).

Key Benefits of GLP-1 Activity

  • Slows gastric emptying and intestinal motility.

  • Promotes a longer-lasting feeling of fullness.

  • Helps reduce appetite and food cravings.

  • Reduces overall calorie intake.

  • Supports weight loss and improved metabolic health.

These effects help individuals manage portion sizes and develop healthier eating habits. Slower digestive motility may also contribute to side effects such as nausea, bloating, and constipation.

GLP-1/GIP and Cellular Energy Metabolism

GLP-1 and GIP receptor agonists, such as tirzepatide, help regulate how the body processes and utilizes fats and glucose for energy. These medications improve insulin sensitivity, enhance glucose uptake by cells, and reduce excess glucose production by the liver.

As caloric intake decreases, the body can increasingly utilize stored fat as an energy source, supporting improvements in overall metabolic health.

Key metabolic benefits include:

  • Increased utilization of stored fat for energy

  • Improved insulin sensitivity and glucose regulation

  • Reduction of excess fat in the liver and other tissues

  • Improved metabolic flexibility

  • Support for sustained weight loss and cardiovascular health

The Endocannabinoid System and Appetite Regulation

The endocannabinoid system plays an important role in regulating hunger, satiety (the feeling of fullness), and energy balance. Cannabinoid receptors (CB1) within the hypothalamus interact with naturally occurring hormones, including leptin, ghrelin, and GLP-1, to help regulate appetite and food intake.

THC typically stimulates appetite and enhances the pleasure associated with eating. In contrast, CBD and THCV may help modulate hunger and reduce appetite through their interactions with cannabinoid receptors, although clinical evidence remains limited.

Understanding these overlapping biological pathways helps explain how cannabinoids may influence eating behavior, weight management, and metabolic health.